Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISRCTN89589002Phase 2Completed
Phase 2, randomised, double-blind trial of propranolol in Parkinson's disease (PD) (2 cohorts), sponsored by Radboud University. Primary endpoints: Tremor-related brain activity and connectivity and Tremor intensity. Started Sep 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ISRCTN89589002.